Deal Library / Pharma BD Deal Intelligence

Gilead Sciences, Inc. — Pharma Deals

The Pharma Closeout tracks 4 deals, $554M in disclosed deal value, 2 with a post-close Outcome Score for Gilead Sciences, Inc..

Median Outcome Score: 64

Best outcome: Gilead Sciences, Inc. / Xilio Therapeutics, Inc. (67)  ·  Weakest outcome: Gilead Sciences, Inc. / MacroGenics, Inc. (60)

All 4 deals

• Gilead Sciences, Inc. / Xilio Therapeutics, Inc. — 2024 · $544M · Largely worked — most objectives met.
• Gilead Sciences, Inc. / MacroGenics, Inc. — 2026 · $10M · Largely worked — most objectives met.
• Gilead Sciences, Inc. / Vir Biotechnology Inc. — 2021
• Gilead Sciences, Inc. / Jounce Therapeutics Inc. — 2020

← Deal Library  ·  Interactive search  ·  How we score deals